Prenatal corticosteroid treatment and accelerated fetal pulmonary maturation. II. Results of clinical studies;Corticotherapie antenatale et acceleration de la maturation foetale. II. Resultats des applications cliniques

Archives de Pediatrie

Volumn 3, Issue 11, 1996, Pages 1119-1128

  Lacaze Masmonteil, T ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

exogenous surfactant; fetal lung maturation; prenatal corticosteroid treatment; prevention; respiratory distress syndrome

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; LUNG SURFACTANT; PROTIRELIN; GLUCOCORTICOID; THYROID HORMONE;

DRUG EFFICACY; FETUS LUNG MATURATION; HUMAN; INCIDENCE; LUNG FUNCTION; MORTALITY; PRENATAL DRUG EXPOSURE; RESPIRATORY DISTRESS SYNDROME; REVIEW; DRUG EFFECT; DRUG INTERACTION; FEMALE; FETUS MATURITY; HYALINE MEMBRANE DISEASE; LUNG; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL CARE; PRENATAL DEVELOPMENT;

DRUG INTERACTIONS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FETAL ORGAN MATURITY; GLUCOCORTICOIDS; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; LUNG; PREGNANCY; PRENATAL CARE; PULMONARY SURFACTANTS; THYROID HORMONES;

EID: 0030296652     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(96)89520-0     Document Type: Article

References (75)

1. 1 Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972-1994. Am J Obstet Gynecol 1995;173:322-35
2. 2 Ballard RA, Ballard PL, Prevention of neonatal respiratory distress syndrome by pharmacological methods. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant, from molecular biology to clinical practice. Amsterdam : Elsevier, 1992:539-60
3. 3 Van Marter LJ, Leviton A, Kuban KCK et al. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics 1990;86:331-6
4. 4 Robertson NRC. Advances in respiratory distress syndrome. Br Med J. 1982;284:917-8
5. 5 Maher JE, Cliver SP, Goldenberg RL et al. The effect of corticosteroid therapy in the very premature infant. Am J Obstet Gynecol 1994;170:869-73
6. 6 Wright LL, Horbar JD, Gunkel H et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995;173:263-9
7. 7 Hallak M, Bottoms SF. Accelerated pulmonary maturation from preterm premature rupture of membranes: a myth. Am J Obstet Gynecol 1993;169:1045-9
8. 8 Lacaze-Masmonteil T. Rupture prématurée des membranes avant terme et accélération de la maturation pulmonaire. In: Dehan M, Frydman R, éds. JPOP 1995: Rupture prématuré des membranes entre 26 et 37 SA. Paris : Douin, 1995:90-6
9. 9 Hudak ML. The use of antenatal steroid therapy for anticipated preterm delivery. In: Witter Fr, Keith LG, eds. Textbook of prematurity. Little, Brown, 1993:185-202
10. 10 Ville Y. Diagnostic de la rupture et diagnostic précoce de l'infection. In: Dehan M, Frydman R, éds. JPOP 1995: Rupture prématuré des membranes entre 26 et 37 SA. Paris : Douin, 1995:78-84
11. 11 Ment LR, Oh W, Ehrenkranz RA et al. Antenal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800
12. 12 Leviton A, Kuban KC, Pagano M et al. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight babies. Pediatrics 1993;91:1083-8
13. 13 Garite TJ, Rumney P, Briggs GG et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992;166:646-51
14. 14 Shankaran S, Bauer CR, Bain R et al. Relationship between antenatal steroid administration and grades III and IV intracranial hemorrhage in low birth weight infants. Am J Obstet Gynecol 1995;173:305-12
15. 15 Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr 1995;126:272-9
16. 16 Halac E, Halac J, Beque EF et al. Prenatal and postnatal corticoseroid therapy do prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990;117:132-8
17. 17 Clyman RI, Ballard PL, Sniderman S et al. Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 1981;98:123-6
18. 18 Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus: a randomized double bind study. Am J Dis Child 1993;147:187-92
19. 19 Waffarn F, Siassi B, Cabal LA, Schmidt PL. Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus. Am J Dis Child 1983;137:336-8
20. 20 Clyman RI, Mauray F, Roman C et al. Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2. J Pediatr 1981;98:126-8
21. 21 Stein HM, Oyama K, Martinez A et al. Effects of corticosteroids in preterm sheep on adaptation ans sympathoadrenal mechanisms at birth. Am J Physiol 1993;264:E763-769
22. 22 Kari MA, Hallman M, Eronen M et al. Prenatal dexamethasone treatment in conjonction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 1994;93:730-6
23. 23 Moise AA, Wearden ME, Kozinetz CA et al. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995; 95:845-50
24. 24 Avery ME. The argument for prenatal administration of dexamethasone to prevent respiratory distress syndrome. J Pediatr 1984;104:240
25. 25 Mugford M, Piercy J, Chalmers I. Cost implications of different approaches to the prevention of respiratory distress syndrome. Arch Dis Child 1991;66:757-64
26. 26 Fiasone J, Jacobs HC, Moya FR et al. Betamethasone increases pulmonary compliance in part by surfactant independent mechanisms in preterm rabbits. Pediatr Res 1987;22:730-75
27. 27 Rider ED, Jobe AH, Ikegami M et al. Antenatal betamethasone dose effects in preterm rabbits studied at 27 days gestation. J Appl Physiol 1990;68:1134-41
28. 28 Snyder JM, Rodgers HF, O'Brien JA et al. Glucocorticoids effects on rabbit fetal lung maturation in vivo: an ultrastructural morphometric study. Anat Rec 1992;232:133-40
29. 29 Lanteri CJ, Willet KE, Kano S et al. Time course of changes in lung mechanics following fetal steroid treatment. Am J Respir Crit Care Med 1994;150:759-65
30. 30 Ikegami M, Berry D, Elkady T et al. Corticosteroids and surfactant change lung function and protein leaks in the lung of ventilated premature rabbits. J Clin Invest 1987;79: 1371-8
31. 31 Ikegami M, Polk D, Tabor B et al. Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function. J Appl Physiol 1991;70:2268-78
32. 32 Frank L, Lewis PL, Sosenko IRS. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985;75:569-74
33. 33 Champigny G, Voilley E, Lingueglia E et al. Regulation of expression of the lung amiloride-sensitive Na+ channel by steroid hormones. EMBO J 1994;13:2177-81
34. 34 Jobe JA. Lung maturational agents and surfactant treatments: are they complementary in preterm infants? J Perinatal 1989;9:14-8
35. 35 Chen CM, Ikegami M, Ueta T et al. Exogenous surfactant function in very preterm lambs with and without fetal corticosteroid treatment. J Appl Physiol 1995;78:955-60
36. 36 Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993;168: 508-13
37. 37 Holm BA. Surfactant replacement therapy: new levels of understanding. Am Rev Respir Dis 1993;148:834-6
38. 38 Ueda T, Ikegami M, Jobe A. Developmental changes of sheep surfactant: in vivo function and in vitro subtype conversion. J Appl Physiol 1994;76:2701-6
39. 39 Ueda T, Ikegami M, Polk D et al. Effects of fetal corticosteroid treatments on postnatal surfactant function in preterm lambs. J Appl Physiol 1995;79:846-51
40. 40 Gunkel JH, Mitchell BR. Observational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacement. Am J Obstet Gynecol 1995;173: 281-5
41. 41 White A, Marcucci G, Andrews E. Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement. Am J Obstet Gynecol 1995;173:286-90
42. 42 Beck JC, Mitzner W, Johnson JWC et al. Betamethasone and the Rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res 1981;15:235-40
43. 43 Massaro D, Teich N, Maxwell S et al. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985;76:1297-305
44. 44 Sahebjami H, Domino M. Effects of postnatal dexamethasone treatment on development of alveoli in adult rats. Exp Lung Res 1989;15:961-9
45. 45 Johnson JW, Mitzner W, Beck JC et al. Long term effects of betamethasone on fetal development. Am J Obstet Gynecol 1981;141:1053-64
46. 46 Ward RM. pharmacologic enhancement of fetal lung maturation. In: Pediatrics in perinatology: fetal drug therapy, vol 21. Philadelphia: WB Saunders, 1994:523-42
47. 47 Post M, Smith BT. Hormonal control of surfactant metabolism. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant, from molecular biology to clinical practice. Amsterdam: Elsevier, 1992:379-424
48. 48 Bourbon JR, Fraslon C. Developmental aspects of the alveolar epithelium and the pulmonary surfactant system. In: Bourbon JR, ed. Pulmonary surfactant: biochemical, functional, regulatory, and clinical concepts. Boca Raton: CRC Press, 1991:257-324
49. 49 Romaguera J, Zorrilla C, De la Vega A et al. Responsiveness of L/S ratio of the amniotic fluid to intra-amniotic administration of thyroxine. Am J Obstet Gynecol Scand 1990;69:119-22
50. 50 Romaguera J, Ramirez M, Adamsons K. Intra-amniotic thyroxine to accelerate fetal maturation. Semin Perinatol 1993;17:260-6
51. 51 Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-7
52. 52 De Zegher F, Spitz B, Devlieger H. Prenatal treatment with thyrotropin releasing hormone to prevent neonatal respiratory distress. Arch Dis Child 1992;67:450-4
53. 53 Moya F, Mena P, Foradori A et al. Effet of maternal administration of thyrotropin releasing hormone on the preterm fetal pituitary-thyroid axis. J Pediatr 1991;119:966-71
54. 54 Ballard PL, Ballard RA, Creasy RK et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with TRH. Pediatr Res 1992;32:673-8
55. 55 ACTOBAT study group. Australian collaborative trial of antenatal thyrotropin-releasing hormone for prevention of neonatal respiratory disease. Lancet 1995;345:877-82
56. 56 Campos GA, Guerra FA, Brümmer E, et al. Synergistic effect of cortisol and TRH on lung maturation in the fetal sheep entails connective tissue maturation. Biol Res 1992;25:95-100
57. 57 Tabor BL, Ikegami M, Jobe AH et al. Dose response of TRH on pulmonary maturation in corticosteroid-treated preterm rabbits. Am J Obstet Gynecol 1990;163:669-76
58. 58 Ikegami M, Polk D, Tabor B et al. Corticosteroid and TRH effects on preterm sheep lung function. J Appl Physiol 1991;70:2268-78
59. 59 Moraga FA, Riquelme RA, Lopez AA et al. Maternal administration of glucocorticoid and TRH enhances fetal lung maturation in undisturbed preterm lambs. Am J Obstet Gynecol 1994;171:729-34
60. 60 Barker PM, Markiewicz M, Parker KA, et al. Synergistic action of T3 and hydrocortisone on epinephrine-induced reabsorbtion of fetal lung liquid. Pediatr Res 1990;27: 588-91
61. 61 Stein HM, Martinez A, Blount L, et al. The effects of corticosteroids and TRH on newborn adaptation and sympathoadrenal mechanisms in preterm sheep. Am J Obstet Gynecol 1994;171:17-24
62. 62 Ikegami M, Jobe AH, Pettenazo A et al. Effects of maternal treatment with corticosteroids, T3, TRH and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis 1987;136:892-8
63. 63 Rodriguez-Pierce M, Sosenko I, Frank L. Prenatal thyroid releasing hormone and thyroid releasing hormone plus dexamethasone lessen the survival of newborn rats during prolonged high O2 exposure. Pediatr Res 1992;32:407-11
64. 64 Morales WJ, O'Brien WF, Angel JF et al. Fetal lung maturation: the combined use of corticosteroids and TRH. Obstet Gynecol 1989;73:111-6
65. 65 Ceriani Cernades J, Fustihara C, Althabe F, Althabe O. Controlled trial of prenatal betamethasone plus TRH for prevention of respiratory distress syndrome in preterm infant. Pediatr Res 1992;32:738-42
66. 66 Ballard RA, Ballard P, Creasy RK et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 1992;339: 510-15
67. 67 Knight DB, Liggins GC, Wealthall SR. A randomized, controlled trial of antepartum TRH and betamethasone in the prevention of respiratory disease in preterm infants. Am J Obstet gynecol 1994;171:11-6
68. 68 Crowther C, Haslam R, Hiller J et al. Thyrotropin-releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms? Am J Obstet Gynecol 1995; 173:719-23
69. 69 Verder H, Robertson B, Greisen G et al. Surfactant therapy and nasal continuous positive pressure for newborns with respiratory distress syndrome. N Engl J Med 1994;331: 1051-5
70. 70 Jacobsen T, Gronvall J, Petersen S, Andersen GE. "Minitouch" treatment of very low-birth-weight infants. Acta Paediatr 1993;82:934-8
71. 71 Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994;36:122-8
72. 72 The OSIRIS collaborative group. Early versus delayed neonatal administration of a synthetic surfactant - the judgment of Osiris. Lancet 1992;340:1363-9
73. 73 Derks JB, Mulder EJH, Visser GHA. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995;102:40-6
74. 74 Pons JC, Fournet P, Magny JF, Frydman R. Prise en charge obstétricale des grossesses triples. In: Dehan M, Frydman R, éds. JPOP 1994: Les grossesses multiples. Paris: Douin, 1994:14-30
75. 75 NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8